|
|
||||||||
The Journal of Immunology, Vol 144, Issue 1 231-238, Copyright © 1990 by American Association of Immunologists
ARTICLES |
JM Tebo and RF Mortensen
Department of Microbiology, Ohio State University, Columbus 43210-1292.
Human C-reactive protein (CRP) is an acute phase reactant that is opsonic and an activator of macrophage tumoricidal function. CRP also activates the classical C cascade. These activities suggest that CRP might interact with monocytes/macrophages via specific receptors in a manner analogous to the interaction of IgG with FcR. With the use of radio-labeled human CRP, we have observed specific binding of CRP to human blood monocytes and the human monocytic cell line U-937. Binding was saturable at a pathophysiologic concentration of CRP, with an estimated KD of 9.5 x 10(-8) M and 3.6 x 10(5) binding sites/cell. Specific binding was inhibited by polyclonal human IgG as well as an IgG1 myeloma. In the converse experiment, CRP failed to inhibit specific [125I]IgG binding. The mAb IV.3, which inhibits binding of IgG immune complexes to FcRII, did not inhibit CRP binding. A 100-fold excess of phosphorylcholine or the phosphorylcholine binding peptide of CRP (residues 47-63) failed to inhibit binding. Although human rIFN- gamma and PMA increased FcRI expression, these reagents had no affect on CRP receptor expression. A single membrane protein of 38 to 41 kDa from U-937 cells was chemically cross-linked to [125I]CRP; the cross- linking was inhibited by human IgG1 but not the IV.3 mAb. Furthermore, two membrane proteins with a Mr of 38 to 40 kDa and 58 to 60 kDa were isolated by CRP ligand-affinity chromatography. These proteins were of a distinct size from those isolated for FcRI from an IgG ligand matrix. These studies demonstrate specific binding of human CRP to a human monocytic cell line via receptors that are distinct from the IgG FcR and implicate CRP in nonspecific, preimmune host defense reaction mediated by cells of the monocytic lineage.
This article has been cited by other articles:
![]() |
C. Rocker, D. E. Manolov, E. V. Kuzmenkina, K. Tron, H. Slatosch, J. Torzewski, and G. U. Nienhaus Affinity of C-Reactive Protein toward Fc{gamma}RI Is Strongly Enhanced by the {gamma}-Chain Am. J. Pathol., February 1, 2007; 170(2): 755 - 763. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Devaraj, T. W. Du Clos, and I. Jialal Binding and Internalization of C-Reactive Protein by Fcgamma Receptors on Human Aortic Endothelial Cells Mediates Biological Effects Arterioscler. Thromb. Vasc. Biol., July 1, 2005; 25(7): 1359 - 1363. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Manolov, C. Rocker, V. Hombach, G. U. Nienhaus, and J. Torzewski Ultrasensitive Confocal Fluorescence Microscopy of C-Reactive Protein Interacting With Fc{gamma}RIIa Arterioscler. Thromb. Vasc. Biol., December 1, 2004; 24(12): 2372 - 2377. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Schwedler, F. Guderian, J. Dammrich, L. A. Potempa, and C. Wanner Tubular staining of modified C-reactive protein in diabetic chronic kidney disease Nephrol. Dial. Transplant., November 1, 2003; 18(11): 2300 - 2307. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Casals, J. Arias-Diaz, F. Valino, A. Saenz, C. Garcia, J. L. Balibrea, and E. Vara Surfactant strengthens the inhibitory effect of C-reactive protein on human lung macrophage cytokine release Am J Physiol Lung Cell Mol Physiol, March 1, 2003; 284(3): L466 - L472. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Chi, S. Tridandapani, W. Zhong, K. M. Coggeshall, and R. F. Mortensen C-Reactive Protein Induces Signaling Through Fc{gamma}RIIa on HL-60 Granulocytes J. Immunol., February 1, 2002; 168(3): 1413 - 1418. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-P. Stein, C. Mold, and T. W. Du Clos C-Reactive Protein Binding to Murine Leukocytes Requires Fc{gamma} Receptors J. Immunol., February 1, 2000; 164(3): 1514 - 1520. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Bharadwaj, M.-P. Stein, M. Volzer, C. Mold, and T. W. Du Clos The Major Receptor for C-Reactive Protein on Leukocytes Is Fc{gamma} Receptor II J. Exp. Med., August 16, 1999; 190(4): 585 - 590. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Torzewski, M. Torzewski, D. E. Bowyer, M. Frohlich, W. Koenig, J. Waltenberger, C. Fitzsimmons, and V. Hombach C-Reactive Protein Frequently Colocalizes With the Terminal Complement Complex in the Intima of Early Atherosclerotic Lesions of Human Coronary Arteries Arterioscler. Thromb. Vasc. Biol., September 1, 1998; 18(9): 1386 - 1392. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Zhong, Q. Zen, J. Tebo, K. Schlottmann, M. Coggeshall, and R. F. Mortensen Effect of Human C-Reactive Protein on Chemokine and Chemotactic Factor-Induced Neutrophil Chemotaxis and Signaling J. Immunol., September 1, 1998; 161(5): 2533 - 2540. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Klein, T. Klein, U. Ruther, and B. Kyewski CD4 T Cell Tolerance to Human C-reactive Protein, an Inducible Serum Protein, Is Mediated by Medullary Thymic Epithelium J. Exp. Med., July 1, 1998; 188(1): 5 - 16. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Xia and D. Samols Transgenic mice expressing rabbit C-reactive protein are resistant to endotoxemia PNAS, March 18, 1997; 94(6): 2575 - 2580. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |